Freedom Investment Management Inc. bought a new position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,771 shares of the company's stock, valued at approximately $296,000.
Other hedge funds have also modified their holdings of the company. Victory Capital Management Inc. acquired a new stake in Tempus AI in the fourth quarter valued at approximately $216,000. China Universal Asset Management Co. Ltd. purchased a new position in Tempus AI during the 4th quarter worth $1,091,000. Mirae Asset Global Investments Co. Ltd. acquired a new position in Tempus AI during the 4th quarter valued at about $178,000. abrdn plc purchased a new stake in Tempus AI in the fourth quarter valued at about $2,784,000. Finally, Dakota Wealth Management boosted its holdings in Tempus AI by 189.7% in the fourth quarter. Dakota Wealth Management now owns 60,668 shares of the company's stock worth $2,048,000 after acquiring an additional 39,724 shares in the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other news, Director Jennifer A. Doudna sold 1,320 shares of the firm's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $90.00, for a total value of $118,800.00. Following the transaction, the director now directly owns 36,011 shares of the company's stock, valued at approximately $3,240,990. This trade represents a 3.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Nadja West sold 809 shares of the company's stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $51.11, for a total transaction of $41,347.99. Following the sale, the director now directly owns 37,705 shares of the company's stock, valued at approximately $1,927,102.55. This represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,146,249 shares of company stock worth $301,185,058 over the last quarter.
Wall Street Analyst Weigh In
A number of research firms recently commented on TEM. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Wolfe Research downgraded Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Morgan Stanley lifted their price target on Tempus AI from $50.00 to $60.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. TD Cowen reissued a "buy" rating and issued a $74.00 price objective (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research report on Thursday, April 10th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $61.08.
Read Our Latest Report on TEM
Tempus AI Stock Performance
TEM stock opened at $40.98 on Tuesday. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The firm has a 50-day simple moving average of $52.83 and a 200-day simple moving average of $50.44. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.
About Tempus AI
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
